XHE vs. IDNA
XHE (SPDR S&P Health Care Equipment ETF) and IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) are both Health & Biotech Equities funds - XHE tracks the S&P Health Care Equipment Select Industry Index while IDNA tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index. Both are passively managed. Over the past 5 years, XHE returned -8.83%/yr vs -8.18%/yr for IDNA. A 0.69 correlation means they provide meaningful diversification when combined. XHE charges 0.35%/yr vs 0.47%/yr for IDNA.
Performance
XHE vs. IDNA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, XHE achieves a -7.82% return, which is significantly lower than IDNA's 19.52% return.
XHE
- 1D
- 1.19%
- 1M
- 0.26%
- YTD
- -7.82%
- 6M
- -9.00%
- 1Y
- 2.70%
- 3Y*
- -5.45%
- 5Y*
- -8.83%
- 10Y*
- 6.15%
IDNA
- 1D
- 1.53%
- 1M
- 6.29%
- YTD
- 19.52%
- 6M
- 16.84%
- 1Y
- 54.42%
- 3Y*
- 11.16%
- 5Y*
- -8.18%
- 10Y*
- —
XHE vs. IDNA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
XHE SPDR S&P Health Care Equipment ETF | -7.82% | -0.23% | 5.08% | -6.23% | -23.34% | 3.04% | 32.91% | 7.82% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 19.52% | 17.26% | -0.72% | -7.63% | -42.28% | -3.98% | 54.30% | 22.10% |
Correlation
The correlation between XHE and IDNA is 0.55, which is moderate. They share some common price drivers but move independently often enough to provide real diversification benefit when combined.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.55 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.60 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.68 |
Correlation (All Time) Calculated using the full available price history since Jun 13, 2019 | 0.69 |
The correlation between XHE and IDNA shifts across timeframes, from 0.55 (1 year) to 0.69 (all time), reflecting how their relationship changes across market environments.
XHE vs. IDNA - Sectors Allocation Comparison
Sectors
XHE
IDNA
Healthcare
Financial Services
-
Industrials
Communication Services
-
Basic Materials
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
XHE
IDNA
Financial Services
XHE
IDNA
-
Industrials
XHE
IDNA
Communication Services
XHE
IDNA
-
Basic Materials
XHE
-
IDNA
-
Consumer Cyclical
XHE
-
IDNA
-
Consumer Defensive
XHE
-
IDNA
-
Energy
XHE
-
IDNA
-
Real Estate
XHE
-
IDNA
-
Technology
XHE
-
IDNA
-
Utilities
XHE
-
IDNA
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
XHE vs. IDNA — Risk / Return Rank
XHE
IDNA
XHE vs. IDNA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for SPDR S&P Health Care Equipment ETF (XHE) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| XHE | IDNA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.07 | ||
| Sortino ratioReturn per unit of downside risk | -2.69 | ||
| Omega ratioGain probability vs. loss probability | 1.04 | 1.34 | -0.31 |
| Calmar ratioReturn relative to maximum drawdown | 0.15 | 5.13 | -4.98 |
| Martin ratioReturn relative to average drawdown | 0.32 | 14.30 | -13.98 |
Loading charts...
Drawdowns
XHE vs. IDNA - Drawdown Comparison
The maximum XHE drawdown since its inception was -49.92%, smaller than the maximum IDNA drawdown of -68.26%. Use the drawdown chart below to compare losses from any high point for XHE and IDNA.
Loading charts...
Drawdown Indicators
| XHE | IDNA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -49.92% | -68.26% | +18.34% |
Max Drawdown (1Y)Largest decline over 1 year | -18.29% | -10.66% | -7.63% |
Max Drawdown (3Y)Largest decline over 3 years | -32.62% | -29.46% | -3.16% |
Max Drawdown (5Y)Largest decline over 5 years | -49.92% | -68.26% | +18.34% |
Max Drawdown (10Y)Largest decline over 10 years | -49.92% | — | — |
Current DrawdownCurrent decline from peak | -38.89% | -41.07% | +2.18% |
Average DrawdownAverage peak-to-trough decline | -13.35% | -36.28% | +22.93% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.46% | 3.82% | +4.64% |
Volatility
XHE vs. IDNA - Volatility Comparison
SPDR S&P Health Care Equipment ETF (XHE) and iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) have volatilities of 7.50% and 7.33%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| XHE | IDNA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.50% | 7.33% | +0.17% |
Volatility (6M)Calculated over the trailing 6-month period | 16.55% | 18.45% | -1.90% |
Volatility (1Y)Calculated over the trailing 1-year period | 22.11% | 24.96% | -2.85% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.56% | 28.47% | -3.91% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 22.99% | 29.51% | -6.52% |
XHE vs. IDNA - Expense Ratio Comparison
XHE has a 0.35% expense ratio, which is lower than IDNA's 0.47% expense ratio.
Dividends
XHE vs. IDNA - Dividend Comparison
XHE's dividend yield for the trailing twelve months is around 0.06%, less than IDNA's 0.90% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 0.90% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% | 0.00% | 0.00% | 0.00% | 0.00% |
XHE SPDR S&P Health Care Equipment ETF | 0.06% | 0.08% | 0.04% | 0.03% | 0.04% | 0.00% | 0.00% | 0.05% | 0.09% | 0.78% | 0.17% | 7.22% |
Frequently Asked Questions
XHE and IDNA have a correlation of 0.55, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
XHE has higher volatility (7.50%) compared to IDNA (7.33%). In terms of maximum drawdown, XHE dropped -49.92% vs IDNA's -68.26%.
On 5-year performance, IDNA leads with -8.18% vs -8.83% for XHE. On fees, XHE is cheaper at 0.35% per year. On volatility, IDNA has been the lower-risk option at 7.33%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, IDNA has performed better with a -8.18% return vs -8.83%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
XHE is cheaper with a 0.35% expense ratio, compared with 0.47% for IDNA.
IDNA has the higher dividend yield at 0.90%, compared with 0.06% for XHE.
XHE tracks S&P Health Care Equipment Select Industry Index, while IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index. They also come from different issuers: State Street and iShares. Their fees differ too: 0.35% for XHE and 0.47% for IDNA.
IDNA currently has the higher Sharpe Ratio (2.19 vs 0.12), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for XHE and IDNA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer